1. Home
  2. FELE vs RYTM Comparison

FELE vs RYTM Comparison

Compare FELE & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FELE
  • RYTM
  • Stock Information
  • Founded
  • FELE 1944
  • RYTM 2008
  • Country
  • FELE United States
  • RYTM United States
  • Employees
  • FELE N/A
  • RYTM N/A
  • Industry
  • FELE Metal Fabrications
  • RYTM Biotechnology: Pharmaceutical Preparations
  • Sector
  • FELE Consumer Discretionary
  • RYTM Health Care
  • Exchange
  • FELE Nasdaq
  • RYTM Nasdaq
  • Market Cap
  • FELE 4.0B
  • RYTM 3.8B
  • IPO Year
  • FELE N/A
  • RYTM 2017
  • Fundamental
  • Price
  • FELE $85.63
  • RYTM $62.15
  • Analyst Decision
  • FELE Hold
  • RYTM Strong Buy
  • Analyst Count
  • FELE 1
  • RYTM 12
  • Target Price
  • FELE $94.00
  • RYTM $76.75
  • AVG Volume (30 Days)
  • FELE 233.9K
  • RYTM 632.6K
  • Earning Date
  • FELE 07-22-2025
  • RYTM 05-07-2025
  • Dividend Yield
  • FELE 1.23%
  • RYTM N/A
  • EPS Growth
  • FELE N/A
  • RYTM N/A
  • EPS
  • FELE 3.83
  • RYTM N/A
  • Revenue
  • FELE $2,015,688,000.00
  • RYTM $136,863,000.00
  • Revenue This Year
  • FELE $5.87
  • RYTM $37.88
  • Revenue Next Year
  • FELE $5.65
  • RYTM $72.84
  • P/E Ratio
  • FELE $22.54
  • RYTM N/A
  • Revenue Growth
  • FELE N/A
  • RYTM 48.88
  • 52 Week Low
  • FELE $78.87
  • RYTM $35.35
  • 52 Week High
  • FELE $111.94
  • RYTM $68.58
  • Technical
  • Relative Strength Index (RSI)
  • FELE 43.72
  • RYTM 53.15
  • Support Level
  • FELE $83.42
  • RYTM $58.72
  • Resistance Level
  • FELE $87.44
  • RYTM $63.24
  • Average True Range (ATR)
  • FELE 1.51
  • RYTM 2.40
  • MACD
  • FELE -0.04
  • RYTM -0.09
  • Stochastic Oscillator
  • FELE 34.00
  • RYTM 71.71

About FELE Franklin Electric Co. Inc.

Franklin Electric Co Inc designs, manufactures, and distributes water and fuel pumping systems, composed of submersible motors, pumps, electronic controls, water treatment systems, and related parts and equipment. It has three segments; The Water Systems segment designs, manufactures and sells motors, pumps, drives, electronic controls, monitoring devices, and related parts and equipment for use in groundwater, water transfer, and wastewater, The Energy Systems segment designs, manufactures and sells pumps, pipe, sumps, fittings, vapor recovery components, electronic controls, monitoring devices, and related parts and equipment for use in fueling system applications and the Distribution segment sells and provides presale support and specifications to the installing contractors.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: